How does a four-ester testosterone blend at 400mg/ml compare to testosterone enanthate alone?

Testosterone enanthate provides a single half-life window of approximately 7–10 days, creating one predictable peak-trough cycle per injection. Testobolin-400 adds rapid-onset propionate and phenylpropionate fractions on top of the longer isocaproate and decanoate fractions, covering multiple pharmacokinetic windows from a single 1 ml dose. The net result is a wider androgenic coverage range that enanthate-only protocols cannot replicate without adding a second compound.

Is Testobolin-400 a better choice than testosterone propionate for a bulking cycle?

Testosterone propionate is exclusively a rapid-onset ester requiring injections every 2–3 days to maintain serum stability. Testobolin-400 includes propionate-equivalent fast fractions alongside sustained-release decanoate, achieving rapid onset without the high injection frequency. For a bulking cycle of 10–16 weeks, the multi-ester blend at 400 mg/ml is more practically administered and pharmacokinetically more stable than a propionate-only protocol at equivalent weekly doses.

What makes Testobolin-400 different from testosterone suspension as a compound choice?

Testosterone suspension contains no ester, entering systemic circulation within hours but clearing within 24 hours — requiring daily or twice-daily injections. Testobolin-400 carries four esterified fractions that extend androgenic activity across 14–21 days from a single administration. For any protocol longer than 2–3 weeks, Testobolin-400 is pharmacologically superior in terms of injection burden, serum stability, and practical cycle management.

Why does the 400mg/ml concentration of Testobolin-400 matter compared to 250mg/ml products?

At 400 mg/ml, Testobolin-400 is the highest-concentration multi-ester testosterone product in its category. An athlete administering 400 mg/week draws exactly 1 ml per injection; the same dose from a 250 mg/ml product requires 1.6 ml. Smaller injection volumes reduce intramuscular depot discomfort, limit injection site irritation over a long cycle, and allow finer dose calibration within a 1 ml ampoule format.

How does the single-dose 10x1ml ampoule format of Testobolin-400 affect sterility compared to multi-dose vials?

Each 1 ml ampoule in the Testobolin-400 pack is a sealed, single-use unit that is opened once and fully expended per injection. Multi-dose vials are punctured repeatedly over weeks, increasing the cumulative contamination risk at the rubber septum. The ampoule format eliminates re-entry contamination entirely — each dose is drawn from a freshly opened sterile container, maintaining pharmacological consistency and microbiological integrity across every administration in a 10-ampoule course. (2) angle_used

Original Product

BM Pharmaceuticals

Testobolin-400 400mg/ml 10x1ml Ampullen by BM Pharmaceuticals

Name: Testobolin-400 400mg/ml 10x1ml Ampoules by BM Pharmaceuticals
Brand: BM Pharmaceuticals
SKU: INJ-TMIX-BM-400-005
Price: 47.00 EUR
Availability: InStock

Testobolin-400 is a four-ester injectable testosterone preparation concentrated at 400 mg/ml by BM Pharmaceuticals, engineered to deliver a pharmacokinetically broad androgenic profile that no single-ester compound can replicate within one administration event. The staggered ester architecture progresses from rapid-onset propionate through to long-depot decanoate, spanning multiple half-life windows simultaneously and eliminating the frequency-versus-stability trade-off that constrains propionate-only or enanthate-only protocols. Each production lot is cleared through ester-resolved HPLC potency verification and LAL endotoxin assay, with lot-traceable Certificates of Analysis issued before any ampoule enters distribution.

€47.00Free shipping on orders over €300

In stock

Ships within 48 h Lab-tested batch

Highest concentration in the multi-ester testosterone segment at 400 mg/ml, cutting required injection volume by 37% versus 250 mg/ml equivalents.
Four-fraction ester architecture spans rapid androgenic onset through sustained 14–21 day release — a pharmacokinetic range no single compound covers alone.
Ten individually sealed 1 ml ampoules prevent cross-injection contamination without the multi-dose vial's repeated-puncture risk.
HPLC verification of each ester fraction independently confirms declared proportions are present in every released batch, not just development-phase samples.
Twice-weekly administration schedule achievable due to decanoate-anchored tail extending serum activity well into the second week.
LAL endotoxin testing performed on finished product before lot release meets parenteral pharmaceutical safety requirements.
Designed for intermediate-to-advanced athletes who require pharmacokinetic flexibility that single-ester protocols cannot provide within a practical injection schedule.

Phase	dosage	Note
Introductory / Comparison Baseline	200–300 mg/week (0.5–0.75 ml)	Establishes a serum baseline comparable to testosterone enanthate 200 mg/week but with faster onset due to propionate fraction; useful for athletes transitioning from single-ester protocols.
Standard Cycle	400 mg/week (1 ml)	One full ampoule twice-weekly at 200 mg/dose; delivers the same androgenic exposure as 1.6 ml of a 250 mg/ml product — practical volume advantage compared to lower-concentration alternatives.
Advanced / High-Volume Phase	600–800 mg/week (1.5–2 ml)	For experienced athletes benchmarking against multi-compound protocols; maintains injection volume below 1 ml per site even at 800 mg/week when split across four ampoule draws.
Taper / Transition to PCT	200 mg/week (0.5 ml) — final 2 weeks	Gradual reduction allows the decanoate fraction to clear progressively; mirrors the washout approach required after any long-ester compound before SERM administration is initiated.

Key takeaways

Choose Testobolin-400 when single-ester compounds cannot cover your full pharmacokinetic window.
Leverage the 400 mg/ml concentration to reduce injection volume versus standard 250 mg/ml blends.
Verify ester-fraction accuracy via BM Pharmaceuticals' HPLC lot-specific Certificates of Analysis.
Administer from sealed single-dose ampoules to eliminate repeated-puncture contamination risk.
Plan twice-weekly injections to exploit all four ester fractions across the release timeline.

Testobolin-400 Defined: A High-Concentration Multi-Ester Testosterone Against the Field

Testobolin-400 is a parenteral testosterone preparation that combines four ester fractions at a total concentration of 400 mg/ml, positioning it as a direct pharmacokinetic alternative to any single-ester testosterone compound on the market. Where testosterone enanthate operates within a single half-life window of approximately 7–10 days, and testosterone propionate clears in roughly 3–4 days, Testobolin-400 bridges both extremes simultaneously through its ester cascade. The four-fraction formula provides androgenic activity that propionate alone initiates rapidly, while decanoate sustains — a span no single-ester product can cover from one injection volume.

Concentration Advantage: 400 mg/ml vs. the Standard Field

At 400 mg/ml, Testobolin-400 delivers 400 mg of testosterone esters per millilitre, compared to the 250 mg/ml standard that dominates the multi-ester testosterone segment. This 60% concentration increase means an athlete targeting 400 mg/week requires only 1 ml per injection rather than 1.6 ml, reducing injection volume directly. Compared to testosterone cypionate at 200–250 mg/ml — the most widely prescribed single-ester pharmaceutical form — Testobolin-400 achieves the same weekly dose at roughly half the injection volume, which is a clinically meaningful advantage for intramuscular depot tolerance.

Pharmacokinetic Breadth Compared to Single-Ester Alternatives

Testobolin-400 covers a pharmacokinetic range that would require at least two separate single-ester compounds to approximate. Testosterone propionate supplies the rapid androgenic onset phase; testosterone phenylpropionate extends activity across the early mid-cycle window; testosterone isocaproate bridges into the second week; testosterone decanoate maintains serum elevation through the later phase. No single-ester product — including the long-acting testosterone undecanoate, which peaks slowly and carries no rapid onset — replicates this combined profile. HPLC analysis performed by BM Pharmaceuticals verifies that each of the four fractions meets its declared proportion within the 400 mg/ml total, confirming that the comparative pharmacokinetic advantage is analytically supported, not theoretical.

Compound Positioning for Specific Goals

Compared to testosterone suspension, which carries no ester and demands daily injection to maintain serum levels, Testobolin-400 reduces administration frequency to twice weekly while maintaining broader androgenic coverage. Compared to testosterone undecanoate injectable at 250 mg/ml, which requires loading doses separated by six weeks in a TRT context, Testobolin-400 establishes stable serum concentrations within the first week of use — a structurally different pharmacokinetic profile suited to cycle-length protocols of 8–16 weeks rather than long-interval TRT scheduling.

Usage

Compare your target weekly dose against your previous single-ester protocol to calibrate starting milligrams: athletes moving from 500 mg/week testosterone enanthate may begin at 400 mg/week Testobolin-400 and adjust based on serum response at week 4.
Split the weekly dose across two administrations — for example Monday and Thursday — to exploit all four ester fractions rather than allowing the short fractions to peak and clear between once-weekly injections.
Draw from a freshly opened 1 ml ampoule for each injection; discard the ampoule immediately after use without storing any partially used volume.
Rotate injection sites (gluteus medius, vastus lateralis) across the cycle to manage the 1 ml oil-based depot volume; the higher concentration means smaller volumes per site compared to equivalent-dose injections from 250 mg/ml products.
Use a 21–23 gauge, 1–1.5 inch needle for intramuscular administration into the selected site; warm the ampoule briefly to body temperature if viscosity requires it.
Record each injection date, volume, and site; cross-reference with bloodwork results at weeks 4 and 8 to compare serum testosterone levels against your baseline from any prior single-ester cycle, allowing direct pharmacokinetic comparison.

Warnings

Contraindications: Testobolin-400 is contraindicated in individuals with known or suspected androgen-sensitive malignancy, active polycythaemia vera, severe hepatic impairment, or hypersensitivity to any component of the oil-based formulation including the sesame or arachis oil vehicle. Cardiovascular disease with uncontrolled hypertension represents an additional contraindication requiring physician clearance before use.

Side_Effects: Aromatase-mediated estrogen conversion may produce gynecomastia, fluid retention, or acne; the 400 mg/ml concentration means that dose measurement errors are pharmacologically amplified compared to lower-concentration products. Androgen-related alopecia progression, increased haematocrit, and suppression of endogenous gonadotropin secretion are expected at doses above physiological replacement range. Injection site reactions including transient nodule formation at the oil depot may occur, particularly with repeat administration to the same anatomical site.

Monitoring: Establish a pre-cycle blood panel covering total and free testosterone, haematocrit, LDL and HDL cholesterol, liver enzymes (ALT, AST), and LH/FSH. Repeat at cycle week 6 — timed as a mid-interval draw between injections — to capture a representative steady-state serum testosterone value rather than a post-injection peak. Haematocrit approaching 52% warrants dose reduction; LDL elevation above 30% of pre-cycle baseline requires lipid-targeted intervention and reassessment of cycle continuation.

PCT: Due to the decanoate fraction's extended clearance kinetics, initiate SERM-based PCT no earlier than 14–18 days after the final injection. Tamoxifen or clomiphene protocols should be timed to this washout window; beginning PCT while decanoate-derived testosterone remains biologically active reduces SERM efficacy by maintaining HPG suppression. Confirm HPG-axis recovery with LH, FSH, and total testosterone bloodwork at PCT weeks 2, 4, and 6.

Frequently asked questions

How does a four-ester testosterone blend at 400mg/ml compare to testosterone enanthate alone?: Testosterone enanthate provides a single half-life window of approximately 7–10 days, creating one predictable peak-trough cycle per injection. Testobolin-400 adds rapid-onset propionate and phenylpropionate fractions on top of the longer isocaproate and decanoate fractions, covering multiple pharmacokinetic windows from a single 1 ml dose. The net result is a wider androgenic coverage range that enanthate-only protocols cannot replicate without adding a second compound.
Is Testobolin-400 a better choice than testosterone propionate for a bulking cycle?: Testosterone propionate is exclusively a rapid-onset ester requiring injections every 2–3 days to maintain serum stability. Testobolin-400 includes propionate-equivalent fast fractions alongside sustained-release decanoate, achieving rapid onset without the high injection frequency. For a bulking cycle of 10–16 weeks, the multi-ester blend at 400 mg/ml is more practically administered and pharmacokinetically more stable than a propionate-only protocol at equivalent weekly doses.
What makes Testobolin-400 different from testosterone suspension as a compound choice?: Testosterone suspension contains no ester, entering systemic circulation within hours but clearing within 24 hours — requiring daily or twice-daily injections. Testobolin-400 carries four esterified fractions that extend androgenic activity across 14–21 days from a single administration. For any protocol longer than 2–3 weeks, Testobolin-400 is pharmacologically superior in terms of injection burden, serum stability, and practical cycle management.
Why does the 400mg/ml concentration of Testobolin-400 matter compared to 250mg/ml products?: At 400 mg/ml, Testobolin-400 is the highest-concentration multi-ester testosterone product in its category. An athlete administering 400 mg/week draws exactly 1 ml per injection; the same dose from a 250 mg/ml product requires 1.6 ml. Smaller injection volumes reduce intramuscular depot discomfort, limit injection site irritation over a long cycle, and allow finer dose calibration within a 1 ml ampoule format.
How does the single-dose 10x1ml ampoule format of Testobolin-400 affect sterility compared to multi-dose vials?: Each 1 ml ampoule in the Testobolin-400 pack is a sealed, single-use unit that is opened once and fully expended per injection. Multi-dose vials are punctured repeatedly over weeks, increasing the cumulative contamination risk at the rubber septum. The ampoule format eliminates re-entry contamination entirely — each dose is drawn from a freshly opened sterile container, maintaining pharmacological consistency and microbiological integrity across every administration in a 10-ampoule course. (2) angle_used

Manufacturer

BM Pharmaceuticals' position within the injectable testosterone market is most clearly defined by its ester specialisation strategy: rather than producing a single reference formulation and scaling it, the company maintains multiple ester-specific and multi-ester blends across a range of concentrations — with Testobolin-400 representing the upper boundary of that concentration range at 400 mg/ml. This specialisation requires that QC infrastructure scales with formulation complexity; a four-ester product at elevated concentration demands ester-resolved HPLC quantification, not simply a total testosterone assay, to confirm that each fraction meets its declared proportion within the 400 mg/ml total. BM Pharmaceuticals applies this fraction-level analytical discipline as a production standard, with lot-specific HPLC data recorded in Certificates of Analysis available per batch. The company's Indian manufacturing base allows this analytical rigour to be maintained without the cost structure of European contract manufacturers, keeping the 400 mg/ml ampoule format commercially accessible while satisfying the potency verification requirements appropriate to a high-concentration parenteral product.

Product details

Brand	BM Pharmaceuticals
Active ingredient	testosterone mix
Also known as	Sustanon, Omnadren, Testosterone-Mischung, Sustanon 250, Testobolin-400, BM Pharmaceuticals Sustanon
Strength	400 mg
Form	Ampullen
Pack size	10 pieces
Item number	INJ-TMIX-BM-400-005

Reviews

No reviews yet. Be the first to review this product.

Write a review

Reviews are written by users of this shop and are checked editorially before publication. Unless labelled “Verified purchase”, we do not verify that the review is based on an actual purchase.

Similar products

Sustandrol 250mg/ml 10x1ml Ampoules by Balkan Pharmaceuticals

GMP Standard

Sustandrol 250mg/ml 10x1ml Ampullen by Balkan Pharmaceuticals

Sustandrol is a GMP-certified injectable testosterone blend formulated at 250 mg/ml in single-dose 1 ml glass ampoules, manufactured by Balkan Pharmaceuticals at their Chișinău facility under validated pharmaceutical production standards. The four-ester testosterone matrix — propionate, phenylpropionate, isocaproate, and decanoate — delivers a multi-phase serum release profile suited to weekly or bi-weekly injection protocols. Every released batch carries verified analytical documentation: container-closure integrity is confirmed through glass-fusion sealing, potency through HPLC quantification, and endotoxin safety through LAL testing before any unit leaves the production site.

€42.00

High Concentration

Suste-Testosterone 250mg 250mg/ml 10ml Vial by Beligas Pharmaceuticals

Suste-Testosterone 250mg by Beligas Pharmaceuticals is a four-ester testosterone blend formulated at 250mg/ml in a 10ml multi-dose vial, purpose-engineered as the continuous androgenic platform around which advanced multi-compound stacks are architecturally constructed. The staggered ester cascade — spanning rapid-onset propionate through extended-release decanoate — sustains uninterrupted androgenic serum coverage that preserves receptor-priming conditions for every co-administered anabolic throughout the full cycle length. Manufacturing quality is anchored by GMP-certified aseptic filling, per-batch HPLC potency verification, and LAL endotoxin clearance; each released lot carries traceable analytical documentation directly linking the vial to its production record.

€39.00

Verified Manufacturer

Suste-Testosterone 400mg 400mg/ml 10ml Vial by Beligas Pharmaceuticals

Suste-Testosterone 400mg is a high-concentration, oil-based injectable testosterone blend containing four distinct ester fractions — propionate, phenylpropionate, isocaproate, and decanoate — combined at 400mg/ml in a 10ml multi-dose vial, engineered to deliver a continuous androgenic release profile across a wide pharmacokinetic window. Each ester contributes a non-overlapping release phase: the shortest ester activates within 24 hours, while the decanoate component sustains serum testosterone for up to 18–21 days per injection cycle. Quality is locked in at two production stages — raw-material identity confirmed by HPLC against certified reference standards, and finished vials cleared by LAL endotoxin assay before lot release.

€48.00

Susten-250 250mg/ml 10x1ml Ampoules by BM Pharmaceuticals

Top Seller

Susten-250 250mg/ml 10x1ml Ampullen by BM Pharmaceuticals

Susten-250 is a four-ester testosterone blend formulated at 250 mg/ml by BM Pharmaceuticals, purpose-suited as the anabolic backbone of structured steroid stacks. Its staggered ester release — from propionate's rapid onset through decanoate's sustained tail — gives stack designers the hormonal continuity needed to support both bulking compounds and lean-mass agents across a full cycle. Every production batch is released only after passing HPLC potency verification and LAL endotoxin screening; sterility is confirmed per pharmacopoeial requirements before any ampoule leaves the facility.

€42.00

Stack it with

Pairs well with these products.

High Concentration

Quant-Equipoise 300mg/ml 10ml Vial by Beligas Pharmaceuticals

Quant-Equipoise by Beligas Pharmaceuticals is a high-concentration injectable anabolic agent delivering 300 mg of Boldenone Undecylenate per millilitre in a 10 ml multi-dose vial, purpose-built for integration into contemporary cycle structures where weekly injection frequency and volume efficiency are primary design criteria. The compound's extended ester profile supports low-frequency administration windows that align with modern 7-day dosing blocks used in both bulking and body-recomposition protocols. Quality assurance is enforced at two independent checkpoints: HPLC-verified potency assay and LAL bacterial endotoxin testing — both completed before batch release under Beligas's GMP-certified production framework.

€47.00

Bolden-250 250mg/ml 10x1ml Ampoules by BM Pharmaceuticals

Long-Acting Formula

Bolden-250 250mg/ml 10x1ml Ampullen by BM Pharmaceuticals

Bolden-250 is a veterinary-derived anabolic compound reformulated for human performance use, delivering Boldenone Undecylenate at 250 mg/ml via single-dose ampoule — distinguished by its exceptionally prolonged plasma half-life of approximately 14 days, which governs the entire pharmacokinetic profile and dictates injection scheduling. The undecylenate ester attached to the boldenone base controls the rate of hydrolysis in muscle tissue, producing a slow, steady release curve that maintains stable serum concentrations over extended periods. Quality verification is built into every step of production: HPLC-confirmed potency, LAL endotoxin screening, and GMP-compliant fill-finish at BM Pharmaceuticals' certified facility.

€48.00

Brand Quality

EquiTrex 350mg/ml 10ml Vial by Concentrex Labs

EquiTrex is a high-concentration boldenone undecylenate injectable — 350 mg per millilitre in a 10 ml vial — engineered to serve distinct roles across both the blast and cruise phases of a structured performance cycle. Its extended ester release supports stable androgen exposure during lower-dose cruise periods while delivering meaningful anabolic output when dose is escalated during a blast. Quality assurance at Concentrex Labs is built on HPLC potency verification and LAL endotoxin screening; every released batch carries documented evidence of sterility and concentration accuracy.

€52.00

Pro Choice

EQ 300 300mg/ml 10ml Vial by Dragon-Pharma

Dragon-Pharma EQ 300 delivers Boldenone Undecylenate at 300 mg/ml in a 10 ml multi-dose vial, formulated specifically for older athletes and TRT-adjacent users who require a mild yet effective anabolic agent to complement age-related hormonal management strategies. Its gradual plasma release profile makes it particularly suited to the steadier hormonal environment that men over 40 typically need to maintain lean mass, bone density support, and nitrogen retention without the volatility of shorter-ester androgens. Quality is assured at the batch level: every vial passes HPLC content verification and LAL endotoxin screening before release under full GMP compliance.

€44.00